rs4986790
|
|
|
0.080 |
GeneticVariation |
BEFREE |
No association between rs4986790 and CAD risk was found.
|
30784241 |
2019 |
rs4986790
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Association between Toll-like receptor 4 Asp299Gly polymorphism and coronary heart disease susceptibility.
|
28793055 |
2017 |
rs4986790
|
|
|
0.080 |
GeneticVariation |
BEFREE |
No association between TLR2-Arg677Trp or TLR4-Asp299Gly and -Thr399Ile gene polymorphisms and the presence or the severity of CAD was observed.
|
25542811 |
2015 |
rs4986790
|
|
|
0.080 |
GeneticVariation |
BEFREE |
TLR4 gene polymorphism (Asp299Gly) attenuates innate immune responsiveness, reduces the risk for coronary artery disease, and increases a chance of longevity.
|
19273219 |
2009 |
rs4986790
|
|
|
0.080 |
GeneticVariation |
BEFREE |
We studied the TLR4 gene Asp299Gly polymorphism in relation to susceptibility to myocardial infarction in a cohort of patients with angiographically documented coronary artery disease, and performed a meta-analysis using data sets from three independent studies.
|
15864121 |
2005 |
rs4986790
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes.
|
15632890 |
2004 |
rs4986790
|
|
|
0.080 |
GeneticVariation |
BEFREE |
Among symptomatic men with documented coronary artery disease, the TLR4 Asp299Gly polymorphism was associated with the risk of cardiovascular events.
|
12742999 |
2003 |
rs4986790
|
|
|
0.080 |
GeneticVariation |
BEFREE |
The findings of this study do not support the hypothesis that the TLR4 Asp299Gly polymorphism influences predisposition to and progression of coronary artery disease.
|
12957699 |
2003 |
rs11536889
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The rs11536879 and rs11536889</span> polymorphisms of TLR4 gene and serum TLR4 protein levels may contribute to the occurrence and development of CAD.
|
31082501 |
2019 |
rs11536889
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Our results demonstrate that TLR4 rs11536889 polymorphism is a novel genetic factor in the development of CAD, influencing the extent and severity of CAD.
|
28002812 |
2017 |
rs11536889
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Thus, the novel interaction between TLR4 rs11536889 and MyD88 rs7744 was related with an increased risk of CAD, that could be strengthened by the presence of hyperglycemia or hyperlipidemia.
|
26959040 |
2016 |
rs4986791
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Our analysis suggests that rs4986791 is negatively associated with CAD risk in Asians but not in Caucasians.
|
30784241 |
2019 |
rs4986791
|
|
|
0.020 |
GeneticVariation |
BEFREE |
No association between TLR2-Arg677Trp or TLR4-Asp299Gly and -Thr399Ile gene polymorphisms and the presence or the severity of CAD was observed.
|
25542811 |
2015 |
rs11536879
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The rs11536879</span> and rs11536889 polymorphisms of TLR4 gene and serum TLR4 protein levels may contribute to the occurrence and development of CAD.
|
31082501 |
2019 |